Literature DB >> 9445010

Regulation of the human proliferating cell nuclear antigen promoter by the adenovirus E1A-associated protein p107.

B H Lee1, M Liu, M B Mathews.   

Abstract

The adenovirus E1A 243R oncoprotein is capable of transactivating the expression of the human proliferating cell nuclear antigen (PCNA) promoter. Mutational analysis of the E1A 243R protein suggested that both its p300/CBP- and p107-binding regions are required for optimal induction of the PCNA promoter (C. Kannabiran, G. F. Morris, C. Labrie, and M. B. Mathews, J. Virol. 67:425-437, 1993). We show that overexpression of p107 antagonizes the induction of PCNA by E1A 243R in transient expression assays. This inhibition is largely independent of p107's ability to interact with E1A 243R, because p107 mutants unable to bind to E1A 243R retain the ability to repress the E1A-activated PCNA promoter. Electrophoretic mobility shift assays with the PCNA promoter detected the presence of p107 in one of the major DNA-protein complexes, EH1, formed with HeLa cell nuclear extracts. Promoter mutations that disrupt the formation of complex EH1 abrogated p107's ability to reverse E1A 243R-induced PCNA expression. The same mutations characterize a sequence important for the binding of transcription factor RFX1 (C. Labrie, G. F. Morris, and M. B. Mathews, Nucleic Acids Res. 23:3732-3741, 1995), implying that p107 antagonizes E1A 243R-induced PCNA expression through this RFX1-binding site. Our data are suggestive of a novel cooperative mechanism for transactivation of PCNA expression, in which E1A 243R relieves transcriptional repression exerted by p107 on the promoter.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9445010      PMCID: PMC124588     

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  67 in total

1.  The retinoblastoma protein binds to a family of E2F transcription factors.

Authors:  J A Lees; M Saito; M Vidal; M Valentine; T Look; E Harlow; N Dyson; K Helin
Journal:  Mol Cell Biol       Date:  1993-12       Impact factor: 4.272

2.  Inhibition of cell proliferation by p107, a relative of the retinoblastoma protein.

Authors:  L Zhu; S van den Heuvel; K Helin; A Fattaey; M Ewen; D Livingston; N Dyson; E Harlow
Journal:  Genes Dev       Date:  1993-07       Impact factor: 11.361

3.  Subunit rearrangement of the cyclin-dependent kinases is associated with cellular transformation.

Authors:  Y Xiong; H Zhang; D Beach
Journal:  Genes Dev       Date:  1993-08       Impact factor: 11.361

4.  Multiple pathways for gene activation in rodent cells by the smaller adenovirus 5 E1A protein and their relevance to growth and transformation.

Authors:  J S Mymryk; S T Bayley
Journal:  J Gen Virol       Date:  1993-10       Impact factor: 3.891

5.  A complex promoter element mediates transactivation of the human proliferating cell nuclear antigen promoter by the 243-residue adenovirus E1A oncoprotein.

Authors:  C Labrie; G F Morris; M B Mathews
Journal:  Mol Cell Biol       Date:  1993-03       Impact factor: 4.272

6.  Interaction of p107 with cyclin A independent of complex formation with viral oncoproteins.

Authors:  M E Ewen; B Faha; E Harlow; D M Livingston
Journal:  Science       Date:  1992-01-03       Impact factor: 47.728

7.  Cloning and sequence of the human nuclear protein cyclin: homology with DNA-binding proteins.

Authors:  J M Almendral; D Huebsch; P A Blundell; H Macdonald-Bravo; R Bravo
Journal:  Proc Natl Acad Sci U S A       Date:  1987-03       Impact factor: 11.205

8.  Human papillomavirus type 16 E7 associates with a histone H1 kinase and with p107 through sequences necessary for transformation.

Authors:  R Davies; R Hicks; T Crook; J Morris; K Vousden
Journal:  J Virol       Date:  1993-05       Impact factor: 5.103

9.  Molecular cloning, structure and expression of the yeast proliferating cell nuclear antigen gene.

Authors:  G A Bauer; P M Burgers
Journal:  Nucleic Acids Res       Date:  1990-01-25       Impact factor: 16.971

10.  Expression and regulation of Escherichia coli lacZ gene fusions in mammalian cells.

Authors:  C V Hall; P E Jacob; G M Ringold; F Lee
Journal:  J Mol Appl Genet       Date:  1983
View more
  7 in total

1.  Genetic alterations of the retinoblastoma-related gene RB2/p130 identify different pathogenetic mechanisms in and among Burkitt's lymphoma subtypes.

Authors:  C Cinti; L Leoncini; A Nyongo; F Ferrari; S Lazzi; C Bellan; R Vatti; A Zamparelli; G Cevenini; G M Tosi; P P Claudio; N M Maraldi; P Tosi; A Giordano
Journal:  Am J Pathol       Date:  2000-03       Impact factor: 4.307

2.  Characterization of dRFX2, a novel RFX family protein in Drosophila.

Authors:  Kyoko Otsuki; Yuko Hayashi; Masaki Kato; Hideki Yoshida; Masamitsu Yamaguchi
Journal:  Nucleic Acids Res       Date:  2004-10-19       Impact factor: 16.971

3.  Downmodulation of E1A protein expression as a novel strategy to design cancer-selective adenoviruses.

Authors:  Hong Jiang; Ramon Alemany; Candelaria Gomez-Manzano; Diana R Medrano; Michael G Lemoine; Melissa V Olson; Marta M Alonso; Ok-Hee Lee; Charles C Conrad; W K Alfred Yung; Juan Fueyo
Journal:  Neoplasia       Date:  2005-08       Impact factor: 5.715

4.  Autorepression of rfx1 gene expression: functional conservation from yeast to humans in response to DNA replication arrest.

Authors:  Yoav Lubelsky; Nina Reuven; Yosef Shaul
Journal:  Mol Cell Biol       Date:  2005-12       Impact factor: 4.272

5.  Regulation of PCNA and cyclin D1 expression and epithelial morphogenesis by the ZO-1-regulated transcription factor ZONAB/DbpA.

Authors:  Tony Sourisseau; Anastasios Georgiadis; Anna Tsapara; Robin R Ali; Richard Pestell; Karl Matter; Maria S Balda
Journal:  Mol Cell Biol       Date:  2006-03       Impact factor: 4.272

Review 6.  RFX1: a promising therapeutic arsenal against cancer.

Authors:  Joby Issac; Pooja S Raveendran; Ani V Das
Journal:  Cancer Cell Int       Date:  2021-05-08       Impact factor: 5.722

7.  Two estrogen response element sequences near the PCNA gene are not responsible for its estrogen-enhanced expression in MCF7 cells.

Authors:  Cheng Wang; Jie Yu; Caleb B Kallen
Journal:  PLoS One       Date:  2008-10-24       Impact factor: 3.240

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.